参考文献/References:
[1] 秦琪, 唐毅, 曲怡达, 等. 利用弥散张量成像技术观察小血管病所致非痴呆型血管性认知障碍患者白质结构损害与认知下降的关系[J]. 首都医科大学学报, 2021, 42(3):373-384. QIN Qi, TANG Yi, QU Yida, et al. Study on the association between white matter connectivity changes and cognitive deficits in vascular cognitive impairment no dementia using diffusion tensor imaging [J]. Journal of Capital Medical University, 2021, 42(3): 373-384.
[2] 张泽阳, 王倩, 陈卓友. 脑小血管病影像学特征及其总体负荷与血管性认知障碍关系的研究进展[J]. 中国脑血管病杂志, 2022, 19(9):642-647. ZHANG Zeyang, WANG Qian, CHEN Zhuoyou. Research progress on the relationship between imaging characteristics and overall burden of cerebral small vessel disease and vascular cognitive impairment[J].Chinese Journal of Cerebrovascular Diseases, 2022, 19(9): 642-647.
[3] ANAMTHATHMAKULA P, WINUTHAYANON W. Prostaglandin-endoperoxide synthase 2(PTGS2) in the oviduct:roles in fertilization and early embryo development[J]. Endocrinology, 2021, 162(4): 1-14.
[4] L?PEZ D E, BALLAZ S J. The role of brain cyclooxygenase-2 (COX-2) beyond neuroinflammation: neuronal homeostasis in memory and anxiety[J].Molecular Neurobiology, 2020, 57(12): 5167-5176.
[5] TYAGI A, KAMAL M A, PODDAR N K. Integrated pathways of COX-2 and mTOR: roles in cell sensing and Alzheimer's disease [J]. Frontiers in Neuroscience, 2020, 14: 693.
[6] LANANNA B V, MCKEE C A, KING M W, et al. Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer’s disease pathogenesis[J]. Science Translational Medicine, 2020, 12(574): eaax3519.
[7] 中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志,2021,16(7):716-726 Cerebral Small Vessel Disease Professional Committee Consensus Writing Group, Chinese Research Hospital Association. Chinese consensus on diagnosis and therapy of cerebral small vessel disease 2021 [J].Chinese Journal of Stroke, 2021, 16(7): 716-726.
[8] 中华医学会老年医学分会老年神经病学组, 脑小血管病认知功能障碍诊疗指南中国撰写专家组, 彭丹涛. 脑小血管病相关认知功能障碍中国诊疗指南(2019)[J]. 中华老年医学杂志,2019,38(4):345-354. Geriatric Neurology Group, Chinese Society of Geriatrics, Clinical Practice Guideline for Cognitive Impairment of Cerebral Small Vessel Disease Writing Group. Clinical practice guideline for cognitive impairment of cerebral small vessel disease of China (2019) [J]. Chinese Journal of Geriatrics, 2019, 38(4): 345-354.
[9] 张春丽, 张颖, 李璐, 等. 脑小血管病患者血清CTRP1 和同型半胱氨酸水平对血管性轻度认知障碍预测价值的研究[J]. 现代检验医学杂志, 2022, 37(1):182-185, 194. ZHANG Chunli, ZHANG Ying, LI Lu, et al. Study on the predictive value of serum CTRP1 and homocysteine levels in patients with cerebral small vessel diseases in vascular mild cognitive impairment[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 182-185, 194.
[10] 黄刚, 王倩, 杨寻, 等. 血清皮质醇对老年脑小血管病患者认知功能损害的影响[J]. 中国老年学杂志, 2023, 43(2):273-276. HUANG Gang, WANG Qian, YANG Xun, et al. Effects of serum cortisol on cognitive impairment in elderly patients with small cerebral vascular disease[J].Chinese Journal of Gerontology, 2023, 43(2): 273-276.
[11] 赵振华, 潘楚锥, 程琼. 血清25 羟基维生素D 与脑小血管病的相关性分析[J]. 福建医科大学学报, 2022, 56(6):504-509, 515. ZHAO Zhenhua, PAN Chuzhui, CHENG Qiong. Correlation analysis between serum 25 hydroxyvitamin D and cerebral small vascular disease[J]. Journal of Fujian Medical University, 2022, 56(6): 504-509, 515.
[12] CHAUHAN G, ROY K, KUMAR G, et al. Distinct influence of COX-1 and COX-2 on neuroinflammatory response and associated cognitive deficits during high altitude hypoxia [J]. Neuropharmacology, 2019, 146: 138-148.
[13] ZHU Liyuan, ZHANG Yuze, GUO Ziyi, et al. Cardiovascular biology of prostanoids and drug Vascular Biology, 2020, 40(6): 1454-1463.
[14] ZHAO Lei, FANG Jinghuan, ZHOU Muke, et al. Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population[J]. BMC Neurology, 2019, 19(1): 291.
[15] WANG Y B, CHEN Z, LI J, et al. Parecoxib improves the cognitive function of POCD rats via attenuating COX-2[J]. European Review for Medical and Pharmacological Sciences, 2019, 23(11): 4971-4979.
[16] ZHU Xinjian, YAO Yuanyuan, YANG Jiurong, et al. COX-2-PGE2 signaling pathway contributes to hippocampal neuronal injury and cognitive impairment in PTZ-kindled epilepsy mice [J]. International Immunopharmacology, 2020, 87: 106801.
[17] IADECOLA C, GOTTESMAN R F. Neurovascular and cognitive dysfunction in hypertension[J]. Circulation Research, 2019, 124(7): 1025-1044.
[18] MAVROUDIS I, CHOWDHURY R, PETRIDIS F, et al. YKL-40 as a potential biomarker for the differential diagnosis of alzheimer's disease[J]. Medicina (Kaunas, Lithuania), 2021, 58(1): 60.
[19] NORDENGEN K, KIRSEBOM B E, HENJUM K, et al. Glial activation and inflammation along the Alzheimer's disease continuum[J]. Journal of Neuroinflammation, 2019, 16(1): 46.
[20] VILLAR-PIQU? A, SCHMITZ M, HERMANN P, et al. Plasma YKL-40 in the spectrum of neurodegenerative dementia[J]. Journal of Neuroinflammation, 2019, 16(1): 145.
[21] 田婧, 白永杰, 尤爱民. 血清Hcy, SAA 和MCP-1 在脑梗死后血管性认知功能障碍患者血清中的表达及意义[J]. 广东医学, 2021, 42(7):810-813. TIAN Jing, BAI Yongjie, YOU Aimin. The expression and clinical value of serum Hcy,SAA and MCP-1 in vascular cognitive dysfunction after cerebral infarction[J]. Guangdong Medical Journal, 2021, 42(7): 810-813.
相似文献/References:
[1]刘辰庚,梁 巍,王培昌.成年人脑脊液CK,AST,LDH和GPx活性检测对脑血管病的鉴别诊断价值[J].现代检验医学杂志,2018,33(05):4.[doi:10.3969/j.issn.1671-7414.2018.05.002]
LIU Chen-geng,LIANG Wei,WANG Pei-chang.Differential Diagnostic Value of CK,AST,LDH and GPx Activity in Adults Cerebrospinal Fluid of Cerebrovascular Diseases[J].Journal of Modern Laboratory Medicine,2018,33(01):4.[doi:10.3969/j.issn.1671-7414.2018.05.002]
[2]杨 瑜,薛 伟,孔 维.腔隙性脑梗死患者血清 Lp-PLA2 及 MIF 水平与认知功能障碍的相关性研究[J].现代检验医学杂志,2021,36(03):132.[doi:10.3969/j.issn.1671-7414.2021.03.030]
YANG Yua,XUE Weib,KONG Weic.Correlation between the Levels of Lp-PLA2 and MIF in Serum andCognitive Dysfunction in Patients with Lacunar Infarction[J].Journal of Modern Laboratory Medicine,2021,36(01):132.[doi:10.3969/j.issn.1671-7414.2021.03.030]
[3]白 雪,董巧云,赵 丽,等.帕金森病患者血清miR-7 和α-Syn 表达水平与认知功能障碍的相关性研究[J].现代检验医学杂志,2023,38(04):78.[doi:10.3969/j.issn.1671-7414.2023.04.014]
BAI Xue,DONG Qiaoyun,ZHAO Li,et al.Correlation between Serum miR-7 and α-Syn Expression Levels and Cognitive Impairment in Patients with Parkinson’s Disease[J].Journal of Modern Laboratory Medicine,2023,38(01):78.[doi:10.3969/j.issn.1671-7414.2023.04.014]
[4]郑德泉,江 华,林锦标,等.帕金森病患者血清NPASDP-4,MBP 水平表达与认知功能障碍及严重程度的诊断价值研究[J].现代检验医学杂志,2024,39(03):17.[doi:10.3969/j.issn.1671-7414.2024.03.003]
ZHENG Dequan,JIANG Hua,LIN Jinbiao,et al.Study on the Diagnostic Value of Serum NPASDP-4 and MBP Level Expression with Cognitive Dysfunction and Severity in Parkinson’s Disease Patients[J].Journal of Modern Laboratory Medicine,2024,39(01):17.[doi:10.3969/j.issn.1671-7414.2024.03.003]
[5]吴雅欣,赵锦华,孟清琳,等.YTHDC1介导ABCB6上调诱导AD小鼠神经元细胞铁死亡促进认知功能障碍机制的实验研究[J].现代检验医学杂志,2024,39(06):54.[doi:10.3969/j.issn.1671-7414.2024.06.009]
WU Yaxin,ZHAO Jinhua,MENG Qinglin,et al.Experimental Study on the Mechanism of YTHDC1 Mediating Upregulation of ABCB6 and Inducing Neuronal Ferroptosis and Promoting Cognitive Dysfunction in AD Mice[J].Journal of Modern Laboratory Medicine,2024,39(01):54.[doi:10.3969/j.issn.1671-7414.2024.06.009]